Karo Bio AB Release: Interim Report January - September 2012

The January-September period and the third quarter 2012 in brief
· Net sales increased to MSEK 24.6 (0.0), whereof the third quarter increased to MSEK 8.1 (0.0)
· Net loss improved to MSEK 89.3 (176.0), whereof the third quarter improved to MSEK 12.6 (51.1)
· Loss per share was SEK 0.23 (0.45), whereof the third quarter SEK 0.03 (0.13)

MORE ON THIS TOPIC